Novel Ureteral Stent Catheterization Technique for Treating Hyperchloremic Metabolic Acidosis After Total Pelvic Exenteration

Anticancer Res. 2023 Nov;43(11):5149-5153. doi: 10.21873/anticanres.16715.

Abstract

Background/aim: Hyperchloremic metabolic acidosis after total pelvic exenteration (TPE) is relatively rare. Urinary diversion of the ileal conduit during TPE can result in increased urine reabsorption leading to hyperchloremic metabolic acidosis. We developed a new technique for the retrograde catheterization of a ureteral stent into an ileal conduit to treat hyperchloremic metabolic acidosis.

Case report: A 70-year-old man underwent TPE for locally recurrent rectal cancer. Multiple episodes of complications, such as hyperchloremia and metabolic acidosis, occurred. Effective drainage of urine from the ileal conduit is crucial. With collaboration between an endoscopist and a radiologist, we developed a novel method for retrograde catheterization of the ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis after TPE. The patient's condition quickly improved after the procedure.

Conclusion: Our novel technique of retrograde catheterization of a ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis could be adopted worldwide, as it is effective and safe.

Keywords: Hyperchloremic metabolic acidosis; retrograde catheterization; total pelvic exenteration.

Publication types

  • Case Reports

MeSH terms

  • Acidosis* / etiology
  • Acidosis* / therapy
  • Aged
  • Drainage
  • Humans
  • Male
  • Pelvic Exenteration* / adverse effects
  • Radiologists
  • Stents